Avanos Medical (AVNS) Cash from Investing Activities (2013 - 2026)

Avanos Medical has reported Cash from Investing Activities for 14 years, with the latest figure at -$7.7 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 15.38% year-over-year to -$7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.2 million (down 71.1% YoY) and the FY2025 annual result came in at -$60.6 million, down 120.36% from the prior year.
• Cash from Investing Activities declined to -$7.7 million in Q1 2026 per AVNS's latest filing, from -$6.8 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $81.0 million in Q4 2023 and troughed at -$121.7 million in Q1 2022.
• A 5-year average of -$12.3 million and a median of -$6.8 million in 2025 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 2035.09% in 2022, then jumped 1753.06% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$4.9 million in 2022, then surged by 1753.06% to $81.0 million in 2023, then tumbled by 109.38% to -$7.6 million in 2024, then advanced by 10.53% to -$6.8 million in 2025, then declined by 13.24% to -$7.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$7.7 million, -$6.8 million, and -$31.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.